A phase I trial of clofarabine in combination with high-dose etoposide and cyclophosphamide and autologous peripheral bloold stem cell transplantation for patients with high-risk or refractory non-Hodgkin's lymphoma.

Trial Profile

A phase I trial of clofarabine in combination with high-dose etoposide and cyclophosphamide and autologous peripheral bloold stem cell transplantation for patients with high-risk or refractory non-Hodgkin's lymphoma.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Mar 2013

At a glance

  • Drugs Clofarabine; Cyclophosphamide; Etoposide
  • Indications Non-Hodgkin's lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Mar 2012 Actual patient number is 18 according to ClinicalTrials.gov.
    • 30 Mar 2012 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
    • 30 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top